Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

516
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
516
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

295
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
295
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

358
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
358
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

430
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
430
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

647
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
647
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

433
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
433

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Genome wide association study meta-analysis of neuropathologic lesions of Alzheimer's disease and related dementias in a multi-site autopsy cohort.

PLoS genetics·2026
Same author

Age-related macular degeneration severity and risk of Alzheimer's disease in older adults in a prospective, community-based cohort study.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026
Same author

Predicting Autopsy-Confirmed Neuropathology across Clinical, Neuroimaging, and CSF Biomarkers using Machine Learning.

bioRxiv : the preprint server for biology·2026
Same author

"We need to keep in mind that battle fatigue": A commentary on moral injury among substance use treatment and community service providers.

Journal of substance use and addiction treatment·2026
Same author

The community representative council of the National Drug Abuse Treatment Clinical Trials Network: Co-design and early impact.

Journal of substance use and addiction treatment·2026
Same author

Intermittent theta burst stimulation for attention deficit hyperactivity disorder.

Brain stimulation·2026

関連する実験動画

Updated: Jan 7, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

16.4K

臨床的特徴

Emma Rhodes1, Rich Jones2, Sheina Emrani1

  • 1Penn Frontotemporal Degeneration Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
まとめ
この要約は機械生成です。

神経精神症候群（NPS）の変動性を明らかにするNPI-Qの新しいバイファクターモデル分析は、総得点によって不明瞭になっていました。この改善された測定（Np）は、様々な認知症の診断に貴重な洞察を提供します。

キーワード:
認知症神経精神症状NPI-Qバイファクターモデル測定の改善

さらに関連する動画

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.7K
Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

6.1K

関連する実験動画

Last Updated: Jan 7, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

16.4K
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.7K
Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

6.1K

科学分野:

  • 神経科学; 精神医学; 老年医学

背景:

  • 神経精神症状（NPS）は認知症で一般的ですが、正確な測定が困難です。; 神経精神症候群インベントリ質問票（NPI-Q）は広く使用されていますが、精度と次元性に限界があります。; NPS測定の改善は、認知症の病態生理と治療の理解に不可欠です。

研究 の 目的:

  • NPI-Qを使用したNPS測定を強化するためのバイファクターモデル分析の可能性を調査すること。; NPSの次元性を評価し、改善された複合スコア（Np）を導き出すこと。; 疾患の重症度および機能障害との関連におけるNpスコアの臨床的有用性を探求すること。

主な方法:

  • 国立アルツハイマー病調整センター（NACC）の51,520人の参加者からのNPI-Qデータに対して、確認的因子分析（CFA）が使用されました。; 一般的なNPS因子と特定の易刺激性/興奮性因子を特定するためにバイファクターモデルが適用されました。; 複合因子スコア（Np）が導き出され、NPI-Q総得点と比較され、疾患の重症度（CDR）および機能障害（FAS）との関連が調査されました。

主要な成果:

  • バイファクターモデルは、一般的なNPS因子と特定の易刺激性/興奮性因子を明らかにしました。; NpスコアはNPI-Q総得点と強く相関しましたが（0.94）、追加の変動性を捉えました。; 前頭側頭型認知症（FTLD）およびレビー小体型認知症（LBD）でより高いNpスコアが観察され、疾患の重症度および機能障害の増大と関連していました。

結論:

  • NPI-Qのバイファクターモデルスコアリングは、認知症におけるNPSの変動性についてのより詳細な理解を提供します。; Npスコアは、多様な認知症診断にわたるNPI-Qデータから貴重な洞察を提供します。; この強化された測定アプローチは、アルツハイマー病および関連認知症（ADRD）におけるNPSの研究および臨床評価を改善する可能性があります。